Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program to Improve the Functioning of Persons Suffering From Post-acute Sequelae of SARS-CoV-2 Infection (PASC): A Randomized Controlled

NCT06156202 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06156202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program to Improve the Functioning of Persons Suffering From Post-acute Sequelae of SARS-CoV-2 Infection (PASC): A Randomized Controlled
Lead sponsor
University of Pennsylvania
Phase
Not applicable
Overall status
Completed
Start date
November 15, 2023
Completion date
November 30, 2025
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, dyspnea, long covid, long covid19, orthostasis, post-acute covid-19, post-acute covid-19 infection, post-acute covid-19 syndrome